Search

Search Constraints

You searched for: Author/Creator Hegde, Priti S.

Search Results

1. Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab. Issue 2 (February 2019)

3. Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade. Issue 4 (7th April 2021)

4. Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment. Issue 1 (12th September 2019)

5. Novel technologies and emerging biomarkers for personalized cancer immunotherapy. Issue 1 (19th January 2016)